secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001493152-25-026883
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic closes initial 11 units of up to 500-unit offering with 12% notes and warrants
--------------------------------------------------------------------------------

- Initial closing of 11 units at $25,000 each in best-efforts offering of up to 500 units.
- Each unit includes a $25,000 note bearing 12% annual interest, due 2 years after final closing.
- Notes convertible into OTLC common at $0.10/share or EdgePoint AI common at $1.00/share.
- Each unit includes 250,000 warrants to buy OTLC common at $0.12/share or 25,000 EdgePoint warrants at $1.25/share.
- Minimum of 10 units required; funds held in escrow until minimum met; offering exempt under Reg D Rule 506.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315225026883/0001493152-25-026883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315225026883/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-026883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer